Single port robotic partial and hemi nephrectomy using a novel single port robotic platform: Pilot study in a pig model

2018 ◽  
Vol 17 (7) ◽  
pp. e2319 ◽  
Author(s):  
S. Crouzet
2010 ◽  
Vol 105 (5) ◽  
pp. 682-685 ◽  
Author(s):  
Sebastien Crouzet ◽  
Georges-Pascal Haber ◽  
Wesley M. White ◽  
Kazumi Kamoi ◽  
Raj K. Goel ◽  
...  

2012 ◽  
Vol 38 (10) ◽  
pp. 1678-1688 ◽  
Author(s):  
In Sik Yun ◽  
Yeo Reum Jeon ◽  
Won Jai Lee ◽  
Jae Wook Lee ◽  
Dong Kyun Rah ◽  
...  

2012 ◽  
Vol 12 (2) ◽  
pp. 5-11 ◽  
Author(s):  
D Mokra ◽  
A Drgova ◽  
R Pullmann ◽  
P Mikolka ◽  
M Antosova ◽  
...  

Changes in Several Inflammatory and Oxidation Markers after Ovalbumin-Sensitization in a Guinea Pig Model of Allergic Asthma - A Pilot Study Ovalbumin (OVA)-sensitization is a common way to evoke changes similar to changes in allergic asthma in humans. Activated cells produce various pro-inflammatory and vasoactive substances including reactive oxygen species. The goal of this pilot study was to evaluate mobilization of leukocytes into the lungs and oxidation processes induced by OVA-sensitization in a guinea-pig model of allergic asthma. Guinea-pigs were divided into OVA-sensitized and naïve animals. After sacrificing animals, blood samples were taken and total and differential leukocyte counts were calculated, and eosinophil cationic protein (ECP) and total antioxidant status (TAS) in the plasma were determined. Left lungs were saline-lavaged and total number of cells and differential leukocyte count in the bronchoalveolar lavage fluid (BAL) were calculated. Right lung tissue was homogenized, ECP, TAS and products of lipid and protein oxidation (thiobarbituric acid-reactive substances and lysine-lipoperoxidation end-products) were determined in the lung homogenate. OVA-sensitization increased a total number of cells and percentages of eosinophils and neutrophils and slightly increased ECP in the blood and in the BAL fluid. In addition, increased lipid and protein oxidation in the lung homogenate, and decreased TAS in the plasma was found in OVA-sensitized compared to naïve animals. In conclusion, OVA-sensitization increased mobilization of leukocytes into the lungs and elevated production of reactive oxygen spesies (ROS), accompanied by a decrease in plasma TAS.


2014 ◽  
Vol 136 (10) ◽  
Author(s):  
Claudio Quaglia ◽  
Gianluigi Petroni ◽  
Marta Niccolini ◽  
Sebastiano Caccavaro ◽  
Paolo Dario ◽  
...  

This paper presents the mechanical design of a novel surgical robotic platform, specifically developed for single-port laparoscopy (SPL). The greatest constraint is the small size of the skin incision through which the robot must operate. Several technical and technological challenges have been tackled to meet the stringent requirements imposed by the surgical procedure at hand. In this paper, a detailed mechanical description of the system is provided, fulfilling the necessary design requirements. The main outcome of this work is a compact, light-weight (total weight approximately 6 kg) and highly dexterous bimanual robot capable of overcoming the current drawbacks experienced in SPL when using traditional medical devices. The system has been assessed in terms of tracking accuracy, resulting in satisfactory and promising performance.


2020 ◽  
Author(s):  
Mariska van den Berg ◽  
Susan Nijboer - Brinksma ◽  
Sophie Bos ◽  
Maarten van den Berge ◽  
David Lamb ◽  
...  

Abstract Background: We hypothesized that TRPA1 channels contribute to airway hyperresponsiveness (AHR) and inflammation in asthma. We evaluated the efficacy of the novel TRPA1 antagonist BI01305834 in a guinea pig model of asthma. Methods: First a pilot study was performed in a guinea pig model of allergic asthma to find the optimal dose of BI01305834. Next, the effect of BI01305834 on AHR to inhaled histamine after the early and late asthmatic reaction (EAR and LAR), magnitude of EAR and LAR and airway inflammation was assessed. Precision-cut lung slices and trachea strips were used to investigate the bronchoprotective and bronchodilating effect of BI01305834. Statistical evaluation of differences of in vivo data was performed using a Mann-Whitney U test or One-way nonparametric Kruskal-Wallis ANOVA, for ex vivo data One- or Two-way ANOVA was used, all with Dunnett’s post-hoc test where appropriate.Results: A dose of 1 mg/kg BI01305834 was selected based on AHR and exposure data in blood samples from the pilot study. In the subsequent study 1 mg/kg BI01305834 inhibited AHR after the EAR, and the development of EAR and LAR elicited by ovalbumin in ovalbumin-sensitized guinea pigs. BI01305834 did not inhibit allergen-induced total and differential cells in the lavage fluid and interleukin-13 gene expression in lung homogenates. Furthermore, BI01305834 was able to inhibit allergen and histamine-induced airway narrowing in guinea pig lung slices, without affecting histamine release, and reverse allergen-induced bronchoconstriction in guinea pig trachea strips.Conclusions: TRPA1 inhibition protects against AHR and the EAR and LAR in vivo and allergen and histamine-induced airway narrowing ex vivo, and reverses allergen-induced bronchoconstriction, independently of inflammation. This effect was partially dependent upon histamine, suggesting a neuronal and possible non-neuronal role for TRPA1 in allergen-induced bronchoconstriction.


Sign in / Sign up

Export Citation Format

Share Document